ECOLAB INC. annual report, FY2014

Full document

Ecolab Inc. — 2014 Form 10-K

Reporting period: Fiscal year ended December 31, 2014; filed February 27, 2015. This is an annual filing, not a standalone fourth-quarter report. Ecolab provides water, hygiene and energy products and services across industrial, institutional, energy and service markets in more than 170 countries.

Financial position and key metrics

  • Sales: Approximately $14 billion in 2014. About 49% of net sales originated outside the United States.
  • Debt: Net debt was approximately $6.4 billion at year-end. Approximately $1.8 billion was floating-rate debt; a one-percentage-point rise in its average interest rate would increase annual interest expense by about $18.5 million.
  • Liquidity: The company had a $2.0 billion, five-year revolving credit facility and a U.S. commercial paper program. The supplied filing text does not state year-end cash, facility availability, or commercial paper outstanding.
  • Profit, cash flow and margins: The supplied text refers to the incorporated annual report for the financial statements and MD&A but does not provide clear 2014 values for net income, operating cash flow, free cash flow, or margins.
  • Capital returns: Ecolab declared quarterly dividends of $0.275 per share in February, May and August 2014 and $0.33 per share in December. It repurchased 720,000 shares under its announced plan in the fourth quarter.

Changes and notable activity

  • 2014 acquisitions included the Purate water-treatment business, AKJ Industries’ chemical division, and dairy hygiene businesses from EXL Laboratories and Hyprod Canada. Their stated pre-acquisition annual sales totaled approximately $69 million; actual 2014 contribution is not provided here.
  • Environmental, health and safety capital expenditures were approximately $53 million in 2014, versus $15 million in 2013. Approximately $63 million was budgeted for 2015, primarily reflecting process-safety work, including at facilities acquired with Champion.
  • Year-end goodwill was $6.7 billion. The filing attributes $4.5 billion to the Nalco transaction and $1.0 billion to Champion, and warns that impairment could result in significant losses.

Outlook, risks and contingencies

  • The supplied text provides no clear numerical earnings or revenue guidance. Management describes ongoing efficiency, ERP, supply-chain and restructuring initiatives, but specific outlook figures and detailed initiative results are not included in the supplied material.
  • Management identifies oil and gas price volatility, weaker activity in some end markets, foreign-exchange movements and international political and regulatory conditions as risks. Venezuela currency issues and uncertainty in emerging markets are specifically noted.
  • Net debt and floating-rate exposure may constrain financial flexibility and increase interest costs. The company also cites acquisition integration, raw-material costs, customer and vendor consolidation, cybersecurity, and execution risks.
  • Environmental remediation accruals were approximately $25 million at year-end; 2014 remediation spending was approximately $5.0 million. Ecolab was involved in cleanup at 25 U.S. sites and nine sites outside the U.S.
  • Nalco had been dismissed from most Deepwater Horizon-related claims, but the filing notes possible appeal and continuing litigation uncertainty. The company also disclosed six wage-hour lawsuits and other environmental and product-related litigation risks.

Investor verification priorities

  1. Review the incorporated annual report’s income statement, balance sheet and cash-flow statement for 2014 results, margins, cash balances and year-over-year comparisons; those values are not clear in the supplied filing text.
  2. Check segment and geographic results, including organic growth, acquisition contributions and the effects of currency movements and energy-market weakness.
  3. Verify gross debt, cash, maturities, covenants, revolver availability and floating-rate exposure against the full debt disclosures.
  4. Assess restructuring costs and benefits, acquisition synergies, goodwill impairment assumptions and the 2015 outlook in the incorporated MD&A.
  5. Track environmental accruals, litigation developments, and planned environmental and safety capital spending.